Literature DB >> 9003342

Central serous chorioretinopathy in patients with systemic lupus erythematosus.

E T Cunningham1, P R Alfred, A R Irvine.   

Abstract

PURPOSE: To describe three patients with systemic lupus erythematosus in whom ophthalmoscopic and fluorescein angiographic evidence of central serous chorioretinopathy developed.
METHODS: The authors retrospectively reviewed the clinical and photographic records of three patients with systemic lupus erythematous in whom central serous chorioretinopathy developed.
RESULTS: Ophthalmoscopic changes observed in these patients with systemic lupus erythematosus included discrete areas of clumping and mottling of the retinal pigment epithelium (RPE), focal RPE detachments, serous elevations of the neurosensory retina, and late subretinal fibrosis with scar formation. Fluorescein angiographic findings included transmission hypofluorescence and hyperfluorescence corresponding to focal RPE alterations, early punctate intense hyperfluorescence corresponding to RPE leaks with progressive filling of sub-RPE detachment spaces, and slow late filing of subretinal detachment spaces.
CONCLUSION: Patients with systemic lupus erythematosus are at increased risk to have central serous chorioretinopathy develop. The pathogenetic implications for an association between systemic lupus erythematosus and central serous chorioretinopathy as well as the similarity to the chorioretinopathy seen with accelerated hypertension, pregnancy, hemodialysis, organ transplantation, and exogenous and endogenous hypercortisolism are discussed. Focal choroidal vasculature compromise with secondary dysfunction of overlying RPE cells is the proposed common mechanism.

Entities:  

Mesh:

Year:  1996        PMID: 9003342     DOI: 10.1016/s0161-6420(96)30385-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review.

Authors:  Aránzazu Mateo-Montoya; Martine Mauget-Faÿse
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  Serous retinal detachment and multiple retinal pigment epithelial detachments, following hemodialysis for multi-organ failure.

Authors:  Soumyava Basu; Taraprasad Das; Tapas Ranjan Padhi
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

4.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

5.  Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.

Authors:  Tanie Natung; Avonuo Keditsu
Journal:  Korean J Ophthalmol       Date:  2015-11-25

6.  Indocyanine green angiography in chronic central serous chorioretinopathy.

Authors:  Urszula Gajdzik-Gajdecka; Mariola Dorecka; Ewa Nita; Anna Michalska; Joanna Miniewicz-Kurowska; Wanda Romaniuk
Journal:  Med Sci Monit       Date:  2012-02

Review 7.  Ocular involvement in connective tissue disorders.

Authors:  Stephanie Young
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

8.  Low-dose aspirin as treatment for central serous chorioretinopathy.

Authors:  Antonio Caccavale; Filippo Romanazzi; Manuela Imparato; Angelo Negri; Anna Morano; Fabio Ferentini
Journal:  Clin Ophthalmol       Date:  2010-08-09

9.  In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy.

Authors:  Nooshin Bazzazi; Mohammad Ahmadpanah; Siamak Akbarzadeh; Mohammad Ali Seif Rabiei; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-28       Impact factor: 2.570

10.  Choroidopathy and kidney disease: a case report and review of the literature.

Authors:  Nirav V Kamdar; Amsalu Erko; Jason S Ehrlich; Jonathan W Kim; Neeraja Kambham; Glenn M Chertow
Journal:  Cases J       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.